Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Embolotherapy Market Report Now Available — 189-Page Study Segments Coils, Vascular Plugs, Detachable Balloons, and Liquid Glue Across 30 Countries

globenewswire.com
ABT Abbott Laboratories is listed as a company profile in a market research report on the Embolotherapy Market. The article does not provide specific sentiment or performance data for Abbott. BDX Becton, Dickinson and Company is listed as a company profile in a market research report on the Embolotherapy Market. The article does not provide specific sentiment or performance data for Becton, Dickinson and Company. BSX Boston Scientific Corporation is listed as a company profile in a market research report on the Embolotherapy Market. The article does not provide specific sentiment or performance data for Boston Scientific Corporation. GEHC GE HealthCare Technologies Inc. is listed as a company profile in a market research report on the Embolotherapy Market. The article does not provide specific sentiment or performance data for GE HealthCare Technologies Inc. JNJ Johnson & Johnson Services Inc. is listed as a company profile in a market research report on the Embolotherapy Market. The article does not provide specific sentiment or performance data for Johnson & Johnson Services Inc. MDLN Medtronic plc is listed as a company profile in a market research report on the Embolotherapy Market. The article does not provide specific sentiment or performance data for Medtronic plc. MDT Merit Medical Systems Inc. is listed as a company profile in a market research report on the Embolotherapy Market. The article does not provide specific sentiment or performance data for Merit Medical Systems Inc. PEN Penumbra Inc. is listed as a company profile in a market research report on the Embolotherapy Market. The article does not provide specific sentiment or performance data for Penumbra Inc. SYK Stryker Corporation is listed as a company profile in a market research report on the Embolotherapy Market. The article does not provide specific sentiment or performance data for Stryker Corporation.

Embolotherapy Market Report Now Available — 189-Page Study Segments Coils, Vascular Plugs, Detachable Balloons, and Liquid Glue Across 30 Countries Dublin, July 09, 2026 (GLOBE NEWSWIRE) -- The "Embolotherapy Market by Embolic Agent Type, Therapeutic Modality, Embolic Persistence, Access Route, Clinical Application, End User, Patient Age Group - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering.

The Embolotherapy Market is on a significant growth trajectory, projected to reach USD 4.06 billion in 2026 and further ascend to USD 6.11 billion by 2032, with a CAGR of 7.01%. This market research report delivers critical insights into embolotherapy, an essential interventional radiology discipline. Utilizing image-guided catheter delivery, it provides therapeutic benefits through intentional blood vessel occlusion. Embolotherapy's applications span hepatocellular carcinoma, uterine fibroids, trauma-related hemorrhage, gastrointestinal bleeding, and more, proving indispensable for decision-makers seeking strategic planning and market entry strategies.

Market Dynamics and Trends

Embolotherapy's market scope is broadening due to a pronounced shift toward minimally invasive procedures. This demand is driven by rising oncology and cardiovascular disease burdens and the widespread adoption of embolic agents like coils, microspheres, and liquid embolics. Hospitals and interventional suites are increasingly prioritizing technologies that enhance procedural precision and outcome repeatability while minimizing inpatient loads. By understanding these dynamics, healthcare providers and industry stakeholders can gain a competitive edge.

Technological Innovations in Embolotherapy

The field is transforming from traditional vessel occlusion techniques to precision embolization. This advancement involves matching device selection with flow dynamics and lesion biology. Emerging tools like drug-eluting beads and advanced liquid embolics are expanding therapeutic options, allowing for more precise control, distribution, and therapeutic targeting. Additionally, new imaging and navigation technologies are enhancing procedural accuracy and decision-making. Integrating such innovations can help industry leaders mitigate risks and leverage emerging opportunities effectively.

The Role of Artificial Intelligence

Artificial intelligence (AI) is subtly revolutionizing embolotherapy by optimizing workflows rather than supplanting physician expertise. Enhanced pre-procedure planning tools aid in lesion detection and treatment simulation, while intra-procedural AI boosts image reconstruction and navigation. Machine learning post-procedure contributes to sophisticated response assessment. This enables organizations to improve strategic and operational efficiencies in clinical settings, providing actionable insights for robust decision support systems.

Regional Insights and Opportunities

In Asia-Pacific, nations such as China, Japan, and India are accelerating embolotherapy through investments in oncology, interventional care, and imaging technologies. Similarly, North America and Europe lead with established radiology networks and device availability, offering robust infrastructure and specialist training that foster market growth. Latin America, the Middle East, and Africa are also advancing, albeit with varied availability due to regional differences in infrastructure and training. By navigating these regional landscapes efficiently, enterprises can enhance their market penetration and strategic positioning.

Impact of Tariffs on the Embolotherapy Market

Global trade dynamics and tariff regulations significantly influence the accessibility and pricing of embolotherapy devices. Understanding tariff implications helps manufacturers and healthcare providers manage import/export challenges effectively, ensuring supply chain continuity and cost efficiency in product offerings.

Key Takeaways from This Report

Key Attributes:

Key Topics Covered:

1. Preface

1.1. Objectives of the Study

1.2. Market Definition

1.3. Market Segmentation & Coverage

1.4. Years Considered for the Study

1.5. Currency Considered for the Study

1.6. Language Considered for the Study

1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction

2.2. Research Design

2.2.1. Primary Research

2.2.2. Secondary Research

2.3. Research Framework

2.3.1. Qualitative Analysis

2.3.2. Quantitative Analysis

2.4. Market Size Estimation

2.4.1. Top-Down Approach

2.4.2. Bottom-Up Approach

2.5. Data Triangulation

2.6. Research Outcomes

2.7. Research Assumptions

2.8. Research Limitations

3. Executive Summary

3.1. Introduction

3.2. CXO Perspective

3.3. Market Size & Growth Trends

3.4. Market Share Analysis, 2025

3.5. FPNV Positioning Matrix, 2025

3.6. New Revenue Opportunities

3.7. Next-Generation Business Models

3.8. Industry Roadmap

4. Market Overview

4.1. Introduction

4.2. Industry Ecosystem & Value Chain Analysis

4.2.1. Supply-Side Analysis

4.2.2. Demand-Side Analysis

4.2.3. Stakeholder Analysis

4.3. Market Dynamics

4.3.1. Key Drivers

4.3.2. Key Restraints

4.3.3. Key Opportunities

4.3.4. Key Challenges

4.4. Porter's Five Forces Analysis

4.5. PESTLE Analysis

4.6. Market Outlook

4.6.1. Near-Term Market Outlook (0-2 Years)

4.6.2. Medium-Term Market Outlook (3-5 Years)

4.6.3. Long-Term Market Outlook (5-10 Years)

4.7. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective

5.2. Consumer Experience Benchmarking

5.3. Opportunity Mapping

5.4. Distribution Channel Analysis

5.5. Pricing Trend Analysis

5.6. Regulatory Compliance & Standards Framework

5.7. ESG & Sustainability Analysis

5.8. Disruption & Risk Scenarios

5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Embolotherapy Market, by Embolic Agent Type

7.1. Coils

7.2. Vascular Plugs

7.3. Detachable Balloons

7.4. Sclerosants

7.5. Liquid Glue

8. Embolotherapy Market, by Therapeutic Modality

8.1. Stent-Assisted Coiling

8.2. Chemoembolization

8.3. Sandwich Technique

9. Embolotherapy Market, by Embolic Persistence

9.1. Temporary Embolics

9.2. Permanent Embolics

10. Embolotherapy Market, by Access Route

10.1. Transarterial

10.2. Transvenous

11. Embolotherapy Market, by Clinical Application

11.1. Oncology

11.2. Neurovascular Disorders

11.3. Peripheral Vascular Disease

11.4. Gynecological Conditions

11.5. Urological Conditions

11.6. Gastrointestinal Bleeding

12. Embolotherapy Market, by End User

12.1. Hospitals

12.2. Ambulatory Surgical Centers

12.3. Specialty Clinics

13. Embolotherapy Market, by Patient Age Group

13.1. Pediatric

13.2. Adult

13.3. Geriatric

14. Asia-Pacific Embolotherapy Market

15. Europe Embolotherapy Market

16. North America Embolotherapy Market

17. Latin America Embolotherapy Market

18. Africa Embolotherapy Market

19. Middle East Embolotherapy Market

20. NATO Embolotherapy Market

21. G7 Embolotherapy Market

22. BRICS Embolotherapy Market

23. European Union Embolotherapy Market

24. ASEAN Embolotherapy Market

25. GCC Embolotherapy Market

26. China Embolotherapy Market

27. United States Embolotherapy Market

28. Japan Embolotherapy Market

29. India Embolotherapy Market

30. Germany Embolotherapy Market

31. United Kingdom Embolotherapy Market

32. Australia Embolotherapy Market

33. France Embolotherapy Market

34. South Korea Embolotherapy Market

35. Italy Embolotherapy Market

36. Canada Embolotherapy Market

37. Russia Embolotherapy Market

38. Brazil Embolotherapy Market

39. Mexico Embolotherapy Market

40. Spain Embolotherapy Market

41. Competitive Landscape

41.1. Market Concentration Analysis, 2025

41.1.1. Concentration Ratio (CR)

41.1.2. Herfindahl Hirschman Index (HHI)

41.2. Recent Developments & Impact Analysis, 2025

41.3. Product Portfolio Analysis, 2025

41.4. Benchmarking Analysis, 2025

42. Company Profiles

42.1. Abbott Laboratories

42.2. ABK Biomedical Inc.

42.3. Acandis GmbH

42.4. Artio Medical Inc.

42.5. B. Braun SE

42.6. Becton, Dickinson and Company

42.7. Boston Scientific Corporation

42.8. Canon Medical Systems Corporation

42.9. Cardinal Health Inc.

42.10. Cook Group Incorporated

42.11. Embolx Inc.

42.12. EndoBar Solutions, LLC

42.13. EndoShape Inc.

42.14. GE HealthCare Technologies Inc.

42.15. Guerbet SA

42.16. IMBiotechnologies Ltd.

42.17. Instylla Inc.

42.18. Johnson & Johnson Services Inc.

42.19. Kaneka Corporation

42.20. Koninklijke Philips N.V.

42.21. Medtronic plc

42.22. Merit Medical Systems Inc.

42.23. Penumbra Inc.

42.24. QT Vascular Ltd.

42.25. Shape Memory Medical Inc.

42.26. Sirtex Medical Limited

42.27. Stryker Corporation

42.28. Surefire Medical Inc.

42.29. Terumo Corporation

42.30. TriSalus Life Sciences Inc.

42.31. Vascular Solutions Inc.

For more information about this report visit https://www.researchandmarkets.com/r/gcf50m

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment